WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Sean Mihaljevich
Associate
Corporate
Palo Alto
smihaljevich@wsgr.com

D650-849-3475

Download vCard
Open PDF

Sean Mihaljevich is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he focuses on corporate and securities law. 

Sean attended Stanford Law School, where he served as a senior editor of the Stanford Law & Policy Review and participated in the Juelsgaard Intellectual Property & Innovation Clinic. While at Stanford, Sean received the Gerald Gunther Prize for outstanding performance in legal research and writing.

Prior to attending law school, Sean worked as a research analyst at the Federal Reserve Bank of New York.

Experience

Sean Mihaljevich is an associate in the Palo Alto office of Wilson Sonsini Goodrich & Rosati, where he focuses on corporate and securities law. 

Sean attended Stanford Law School, where he served as a senior editor of the Stanford Law & Policy Review and participated in the Juelsgaard Intellectual Property & Innovation Clinic. While at Stanford, Sean received the Gerald Gunther Prize for outstanding performance in legal research and writing.

Prior to attending law school, Sean worked as a research analyst at the Federal Reserve Bank of New York.

Education
  • J.D., Stanford Law School, 2021

    Senior Editor, Stanford Law & Policy Review; Juelsgaard Intellectual Property & Innovation Clinic; Gerald Gunther Prize for outstanding performance in legal research and writing

  • B.A., Economics, Wesleyan University, 2016

    Phi Beta Kappa, Omicron Delta Epsilon (international economics honor society), Lebergott-Lovell Prize for best economics paper, White Prize for advanced study in economics

Admissions
  • State Bar of California
Credentials
Education
  • J.D., Stanford Law School, 2021

    Senior Editor, Stanford Law & Policy Review; Juelsgaard Intellectual Property & Innovation Clinic; Gerald Gunther Prize for outstanding performance in legal research and writing

  • B.A., Economics, Wesleyan University, 2016

    Phi Beta Kappa, Omicron Delta Epsilon (international economics honor society), Lebergott-Lovell Prize for best economics paper, White Prize for advanced study in economics

Admissions
  • State Bar of California
Focus Areas
  • Corporate
  • Emerging Companies and Venture Capital
  • Public Company Representation
Recent Insights
Client Highlights
Wilson Sonsini Advises Encoded Therapeutics on $275 Million Series F
On September 9, 2026, Encoded Therapeutics, a clinical-stage biotechnology company developing precision genetic medicines for severe neurological disorders, announced it closed a $275 million Series F financing co-led by GV and another healthcare fund, with participation from ARCH Venture Partners, Braidwell LP, Farallon Capital Management, Illumina Ventures, Invus, Janus Henderson Investors, Matrix Capital Management, Nolan Capital, RTW Investments, SoftBank Vision Fund 2, and Venrock. Wilson Sonsini Goodrich & Rosati advised Encoded Therapeutics on the transaction.
Learn More
Client Highlights
Wilson Sonsini Advises Beren Therapeutics P.B.C. on $300 Million Financing, Including Equity and Debt and Royalty Facilities
On June 10, 2026, Beren Therapeutics P.B.C., a leader in cholesterol trafficking biology and cyclodextrin-based therapeutics, announced it has secured $300 million in combined financing. The financing consists of:
Learn More
View All
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.